"I think first and foremost, the most exciting part is the ability to build a women's health-focused company and to be the only one doing it, to be the most focused company on women's health, which is an area that it is about time," Organon managing director Nirelle Tolstoshev told BioPharmaDispatch. …
The 'new' Organon springs to life after MSD spinout
June 3, 2021 Latest NewsBioPharmaBioPharmaDispatch Executive
Latest Video
New Stories
-
Australia 'is not an island' on pricing and we cannot be so arrogant to expect free product
August 13, 2026 - - Latest News -
Survey exposes deep gaps in neurological care across Australia
August 13, 2026 - - Latest News -
US childhood vaccine move away from combinations contrasts with Australia’s national schedule
August 12, 2026 - - Latest News -
Former minister joins DBG Health board as company broadens healthcare ambition
August 12, 2026 - - Latest News -
A sage appointment that puts DBG Health another step closer to a serious understanding of decision-making
August 12, 2026 - - Latest News -
Patients welcome the timely PBS listing of rare cancer therapy
August 12, 2026 - - Latest News -
How education exposes the moral and ethical limits of our health decision-making
August 11, 2026 - - Latest News